Plus Therapeutics Inc (NASDAQ:PSTV) price on current trading day, rose 4.96% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.84.
A look at the stock’s price movement, the close in the last trading session was $0.80, moving within a range at $0.75 and $0.86. The beta value (5-Year monthly) was 0.673. Turning to its 52-week performance, $2.67 and $0.24 were the 52-week high and 52-week low respectively. Overall, PSTV moved -41.27% over the past month.
Plus Therapeutics Inc’s market cap currently stands at around $14.27 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-26.
The average forecast suggests down to a -33.66% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 4.86M, representing a -16.51% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PSTV is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
PSTV’s current price about -12.78% and -20.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.83, while 7-day volatility ratio is 15.44% and 34.70% in the 30-day chart. Further, Plus Therapeutics Inc (PSTV) has a beta value of 0.87, and an average true range (ATR) of 0.26.
If we refocus on Plus Therapeutics Inc (NASDAQ:PSTV), historical trading data shows that trading volumes averaged 3.43 over the past 10 days and 16.13 million over the past 3 months. The company’s latest data on shares outstanding shows there are 17.00 million shares.
The 2.55% of Plus Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 11.11% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.93 million on 2025-03-14, giving us a short ratio of 0.04. The data shows that as of 2025-03-14 short interest in Plus Therapeutics Inc (PSTV) stood at 1607.0 of shares outstanding, with shares short rising to 59847.0 registered in 2025-02-14. Current price change has pushed the stock -26.97% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PSTV stock continues to rise going into the next quarter.
